Main description:

Fully updated and expanded, in full color with intuitive icons throughout, packed with new and expanded comparison charts, and with patient handouts as printable PDFs - the classic reference to psychotropic medications is now more "userfriendly" than ever! The Clinical Handbook of Psychotropic Drugs has become a standard reference and practical tool for psychiatrists, psychiatric nurses, pharmacists, psychologists, physicians, and all mental health professionals.The new and fully updated 19th edition retains all the practical features for which the Clinical Handbook is renowned: Independent, unbiased Packed with unique comparison charts (dosages, side effects, pharmacokinetics, interactions - ) that allow you to see at a glance which medication is the most suitable for each patient Instantly recognizable icons and full color throughout, allowing you to find at a glance all the information you seek The latest information on newly released drugs, adverse effects, approved indications (see below for details) Succinct, bulleted information on all classes of medication: classification, available products (including US and Canadian trade names), on- and off-label indications (US FDA and Canada); pharmacology, dosing, pharmacokinetics; adverse effects, precautions, contraindications, toxicity; lab tests, precautions in young, old, and pregnant patients, nursing implications; drug interactions; patient instructions - all you need to know for each class of drug!
The latest information on Herbal and "Natural" Products, Unapproved Treatments, ECT, BLT, rTMS Patient handouts as printable PDFs New in this edition: Substantial updates on antipsychotic dosages (2nd generation); Pharmacogenomics information for dementia drugs; Recent drugs / preparations added, such as Forfivo (bupropion), Levate (amitriptyline), Impril (imipramine pamoate), Mazepine (carbamazepine), Stavzor (valproate), Gralise (gabapentin), Horizant (gabapentin enacarbil), Trokendi XR (topiramate); Revised classification of antidepressants: vilazodone (Viibryd) as Serotonin-1A Agonist/Serotonin Reuptake Inhibitor

Contents:

Table of Contents (preliminary) Antidepressants Selective Serotonin Reuptake Inhibitors (SSRI) Norepinephrine Dopamine Reuptake Inhibitor (NDRI) Serotonin Norepinephrine Reuptake Inhibitor (SNRI) Serotonin-2 Antagonists/Reuptake Inhibitors (SARI) Serotonin-1A Agonist/Serotonin Reuptake Inhibitor Noradrenergic/Specific Serotonergic Antidepressants (NaSSA) Non-Selective Cyclic Antidepressants Monoamine Oxidase Inhibitors Reversible Inhibitor of MAO-A (RIMA) Irreversible Monoamine Oxidase (A&B) Inhibitors (MAOIs) Irreversible Monoamine Oxidase B Inhibitor Effects of Antidepressants on Neurotransmitters/Receptors Pharmacological Effects of Antidepressants on Neurotransmitters/Receptors Frequency of Adverse Reactions to Antidepressants at Therapeutic Doses Antidepressant Doses and Pharmacokinetics Switching Antidepressants Antidepressant Augmentation Strategies Electroconvulsive Therapy (ECT) Bright-Light Therapy (BLT) Repetitive Transcranial Magnetic Stimulation (rTMS) Antipsychotics "Second-Generation" Antipsychotics/SGAs "Third-Generation" Antipsychotic/TGA "First Generation" Antipsychotics/FGAs Effects of Antipsychotics on Neurotransmitters/Receptors Pharmacological Effects of Antipsychotics on Neurotransmitters/ Receptors Frequency (%) of Adverse Reactions to Antipsychotics at Therapeutic Doses Antipsychotic Doses and Pharmacokinetics (Oral and Short-Acting Injections) Comparison of Long-acting IM Antipsychotics Extrapyramidal Adverse Effects of Antipsychotics Switching Antipsychotics Antipsychotic Augmentation Strategies Agents for Treating Extrapyramidal Side Effects Effects on Extrapyramidal Symptoms Comparison of Agents for Treating Extrapyramidal Side Effects Doses and Pharmacokinetics of Agents for Treating Extrapyramidal Side Effects Anxiolytic (Antianxiety) Agents Benzodiazepines Comparison of the Benzodiazepines Buspirone Hypnotics/Sedatives L-Tryptophan Comparison of Hypnotics/Sedatives Mood Stabilizers Lithium Anticonvulsants Comparison of Anticonvulsants Comparison of Adverse Reactions to Mood Stabilizers at Therapeutic Doses Drugs for ADHD Psychostimulants Atomoxetine Comparison of Drugs for ADHD Alpha-2 Agonists Augmentation Strategies in ADHD Drugs for Treatment of Dementia Cholinesterase Inhibitors Memantine Comparison of Drugs for Treatment of Dementia Sex-Drive Depressants Comparison of Sex-Drive Depressants Drugs of Abuse Alcohol Stimulants Hallucinogens Opiates/Narcotics Inhalants/Aerosols Gamma-hydroxy Butyrate (GHB)/Sodium Oxybate Flunitrazepam (Rohypnol) Nicotine/Tobacco Treatment of Substance Use Disorders Disulfiram Acamprosate Naltrexone Methadone Buprenorphine Pharmacotherapy for Nicotine/Tobacco Use Dependence Unapproved Treatments of Psychiatric Disorders Adrenergic Agents Dopaminergic Agents GABA Agents/Anticonvulsants Hormones NMDA Agents Miscellaneous Herbal and "Natural" Products Glossary Resources for Information on Drug Use in Pregnancy and Effectson Breast Milk Patient Information Sheets Index of Drugs